2026 Edward E. Walsh: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	92	998	908	543	485	253	35366
Medicine	92	11205	10531	5758	5325	255	35366

Overview

Edward E. Walsh is affiliated with the University of Rochester Medical Center in the United States. Their research predominantly centers on medical sciences, with a significant focus on epidemiology and infectious diseases within the broader field of medicine.

The scientist's recent papers include the following:

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates, 2020, published in New England Journal of Medicine
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, 2020, published in Nature
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults, 2023, published in New England Journal of Medicine
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3, 2021, published in New England Journal of Medicine
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults, 2023, published in New England Journal of Medicine

Coauthors who have frequently collaborated with Edward E. Walsh include:

Ann R. Falsey
Angela R Branche
Thomas J. Mariani
Alejandra Gurtman
Kena A. Swanson

The scientist has published extensively in several venues. These include:

Open Forum Infectious Diseases
The Journal of Infectious Diseases
bioRxiv (Cold Spring Harbor Laboratory)
New England Journal of Medicine
Clinical Infectious Diseases

Main fields of study covered by Edward E. Walsh are medicine, with subfields emphasizing epidemiology, infectious diseases, pulmonary and respiratory medicine, cardiology and cardiovascular medicine, and surgery.

The primary topics addressed in their research encompass:

Respiratory viral infections research
SARS-CoV-2 and COVID-19 research
Pneumonia and respiratory infections
Viral gastroenteritis research and epidemiology
Neonatal respiratory health research
Tracheal and airway disorders
Congenital diaphragmatic hernia studies

Best Publications

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

2629
Citations
Respiratory syncytial virus infection in elderly and high-risk adults.

Ann R. Falsey;Patricia A. Hennessey;Maria A. Formica;Christopher Cox

2529
Citations
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Evelyn A. Kurt-Jones;Lana Popova;Laura Kwinn;Lia M. Haynes

2215
Citations
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

1672
Citations
Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus

Caroline Breese Hall;Edward E. Walsh;Christine E. Long;Kenneth C. Schnabel

1070
Citations
Respiratory Syncytial Virus Infection in Adults

Ann R. Falsey;Edward E. Walsh

904
Citations
Human Metapneumovirus Infections in Young and Elderly Adults

Ann R Falsey;Dean Erdman;Larry J Anderson;Edward E Walsh

796
Citations
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Hall Cb;McBride Jt;Walsh Ee;Bell Dm

748
Citations
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.

Unknown

676
Citations
Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Jessica L. Halliley;Jessica L. Halliley;Christopher M. Tipton;Jane Liesveld;Alexander F. Rosenberg

544
Citations
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

John DeVincenzo;Robert Lambkin-Williams;Tom Wilkinson;Jeffrey Cehelsky

524
Citations
Occurrence of Groups A and B of Respiratory Syncytial Virus over 15 Years: Associated Epidemiologic and Clinical Characteristics in Hospitalized and Ambulatory Children

Caroline Breese Hall;Edward E. Walsh;Kenneth C. Schnabel;Christine E. Long

472
Citations
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

Natalie I Mazur;Deborah Higgins;Marta C Nunes;José A Melero

471
Citations
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.

G A Prince;A B Jenson;V G Hemming;B R Murphy

453
Citations
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.

B R Murphy;G A Prince;E E Walsh;H W Kim

433
Citations
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.

E E Walsh;J Hruska

422
Citations
Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1

Jacob J. Schlesinger;Michael W. Brandriss;Edward E. Walsh

418
Citations
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.

P R Johnson;R A Olmsted;G A Prince;B R Murphy

393
Citations
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

Ann R Falsey;Robert W Frenck;Edward E Walsh;Nicholas Kitchin

373
Citations
Severity of Respiratory Syncytial Virus Infection Is Related to Virus Strain

Edward E. Walsh;Kenneth M. McConnochie;Christine E. Long;Caroline B. Hall

347
Citations
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.

Sara M. Johnson;Sara M. Johnson;Beth A. McNally;Beth A. McNally;Ioannis Ioannidis;Ioannis Ioannidis;Emilio Flano;Emilio Flano

325
Citations
Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.

J J Schlesinger;M W Brandriss;E E Walsh

324
Citations

Frequent Co-Authors

Ann R. Falsey University of Rochester

David J. Topham University of Rochester Medical Center

Caroline B. Hall University of Rochester

Steven R. Gill University of Rochester Medical Center

Janet A. Englund Seattle Children's Hospital

Philip R. Dormitzer Pfizer (United States)

Larry J. Anderson Emory University

Barney S. Graham Morehouse School of Medicine

Kathrin U. Jansen Pfizer (United States)

David A. Cooper University of New South Wales

External Links

Personal website of Edward E. Walsh

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students find enrolling in easiest absn program to get into helpful when transitioning into nursing, combining accelerated paths with foundational medical knowledge.

Similarly, starting with the best easiest lpn programs to get into offers a gateway into patient care, fostering essential clinical skills that complement immunological studies.

Advancing further, many pursue advanced practice roles through nurse practitioner programs with easy admission, which integrate clinical expertise with leadership in healthcare settings.

For those focusing on mental health and immunology's intersection, enrolling in the top online pmhnp programs can provide excellent clinical placements and specialized training.

These pathways emphasize flexible online options with streamlined admissions and strong practical training, making them accessible for students aiming to enhance their credentials in immunology-related healthcare careers.